Donatello Gasparro

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

Arlene O. Siefker‐Radtke, Andrea Necchi, Se Hoon Park et al. · The Lancet Oncology · 2022 · 162 citations · Full text

Urology, Oncology, Metastatic Urothelial Carcinoma +7

Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma

Cecilia Bozzetti, Francesca Negri, Costanza Annamaria Lagrasta et al. · British Journal of Cancer · 2011 · 150 citations · Full text

Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis

Sergio Bracarda, Roberto Iacovelli, Luca Boni et al. · Annals of Oncology · 2015 · 105 citations · Full text

Urology, Oncology, Genitourinary Cancer +5

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study

Orazio Caffo, Ugo De Giorgi, Lucia Fratino et al. · European Urology · 2014 · 83 citations · Full text

Italian Multicentre Study, Urology, Genitourinary Cancer +9

Comparison Between Epidermal Growth Factor Receptor (EGFR) Gene Expression in Primary Non-small Cell Lung Cancer (NSCLC) and in Fine-Needle Aspirates from Distant Metastatic Sites

Cecilia Bozzetti, Marcello Tiseo, Costanza Annamaria Lagrasta et al. · Journal of Thoracic Oncology · 2008 · 63 citations · Full text

Oncology, Medicine, Pathology +9